?

Reese David M

EVP & Chief Technology Officer
Amgen Inc.
US, Thousand Oaks [HQ]
CIK 1748434

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
59,976
Price per Share :
$272.11
Equivalence :
$16,320,069.36

Transaction History

  • 59,976 Shares After Transaction
    Value : $16,576,166.88
    $190,702.20
    04/30/24
  • Footnotes:
    #1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 1,363 RSUs which will vest on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
    #2 These shares include 694 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • 59,326 Shares After Transaction
    Value : $16,455,252.62
    $180,290.50
    05/02/24
  • 61,889 Shares After Transaction
    Value : $n/a
    $0.0
    05/07/24
  • 66,653 Shares After Transaction
    Value : $n/a
    $0.0
    03/06/24
  • 60,666 Shares After Transaction
    Value : $16,311,267.42
    $1,667,531.74
    03/18/24

Get PRO Today.

PRO unlocks 1 more insider transactions made by Reese David M